Our history
Our experience and expertise date back more than 60 years. Discover our history
Louvain-la-Neuve, Belgium – September 5th, 2024 – The Minafin Group, a leading developer and producer of fine chemicals, today announced the appointment of Olivier Ubrich as CEO of its Health … Learn More
Louvain-la-Neuve, June 19th, 2024 – Vinorelbine is an important drug substance used to treat breast and lung cancers. Minakem is the sole API manufacturer located in Europe. This molecule remains … Learn More
Minakem’s investment in a new production unit in Lassalle, Montreal, for corticosteroid APIs reflects the company’s recognition of the importance and growing demand for these active pharmaceutical ingredients (API). The … Learn More
Montreal, April 8th, 2024 – The COVID-19 pandemic has prompted North America and Europe to reconsider the feasibility of slightly rebalancing their supply chains, which currently heavily rely on Asia. … Learn More
You are welcome to meet our APIs generics sales team to exchange about your new DP projects requiring an API or to evaluate opportunity to qualify Schedule a meeting
API Solutions for Your DP Projects Looking for a reliable API supplier? Our generics sales team is here to discuss your specific needs. Whether Schedule a meeting
You are welcome to meet our APIs generics sales team to exchange about your new DP projects requiring an API or to evaluate opportunity to qualify Schedule a meeting
Minakem will be present at CPHI Japan to exchange on your API / HAPI supply request. For meeting us, please contact : contact@minakem.com If Schedule a meeting